Gene · 8726
Papers3,114
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
201 to 220 of 3,114
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| FOXM1, MEK, and CDK4/6: New Targets for Malignant Peripheral Nerve Sheath Tumor Therapy. | Int J Mol Sci | 2023 | 37686402 | PubTator, text mining | PubMed |
| Current Advances in Cellular Approaches for Pathophysiology and Treatment of Polycystic Ovary Syndrome. | Cells | 2023 | 37681921 | PubTator, text mining | PubMed |
| Activation of AKT induces EZH2-mediated β-catenin trimethylation in colorectal cancer. | iScience | 2023 | 37670785 | PubTator, text mining | PubMed |
| Targeting reversible post-translational modifications with PROTACs: a focus on enzymes modifying protein lysine and arginine residues. | J Enzyme Inhib Med Chem | 2023 | 37667522 | PubTator, text mining | PubMed |
| Non-canonical functions of EZH2 in cancer. | Front Oncol | 2023 | 37664059 | PubTator, text mining | PubMed |
| JARID2 coordinates with the NuRD complex to facilitate breast tumorigenesis through response to adipocyte-derived leptin. | Cancer Commun (Lond) | 2023 | 37658635 | PubTator, text mining | PubMed |
| Editorial: Community series in epigenetics of the immune component of inflammation-volume II. | Front Immunol | 2023 | 37654499 | PubTator, text mining | PubMed |
| RBFOX2 recognizes N6-methyladenosine to suppress transcription and block myeloid leukaemia differentiation. | Nat Cell Biol | 2023 | 37640841 | PubTator, text mining | PubMed |
| Branched-chain amino acids catabolism and cancer progression: focus on therapeutic interventions. | Front Oncol | 2023 | 37637065 | PubTator, text mining | PubMed |
| Type I Interferon Pathway-Related Hub Genes as a Potential Therapeutic Target for SARS-CoV-2 Omicron Variant-Induced Symptoms. | Microorganisms | 2023 | 37630661 | PubTator, text mining | PubMed |
| Beyond Bruton's tyrosine kinase inhibitors in mantle cell lymphoma: bispecific antibodies, antibody-drug conjugates, CAR T-cells, and novel agents. | J Hematol Oncol | 2023 | 37626420 | PubTator, text mining | PubMed |
| Methylation across the central dogma in health and diseases: new therapeutic strategies. | Signal Transduct Target Ther | 2023 | 37620312 | PubTator, text mining | PubMed |
| RepID represses megakaryocytic differentiation by recruiting CRL4A-JARID1A at DAB2 promoter. | Cell Commun Signal | 2023 | 37612584 | PubTator, text mining | PubMed |
| RNF4 and USP7 cooperate in ubiquitin-regulated steps of DNA replication. | Open Biol | 2023 | 37607592 | PubTator, text mining | PubMed |
| MPNST of the abdominal wall in a patient with lynch syndrome: A case report of a rare presentation and unique association. | Int J Surg Case Rep | 2023 | 37603917 | PubTator, text mining | PubMed |
| Elucidation of genome-wide understudied proteins targeted by PROTAC-induced degradation using interpretable machine learning. | PLoS Comput Biol | 2023 | 37590332 | PubTator, text mining | PubMed |
| LncRNA HOTAIR Enhances Epithelial-to-mesenchymal Transition to Promote the Migration and Invasion of Liver Cancer by Regulating NUAK1 via Epigenetic Inhibition miR-145-5p Expression. | J Cancer | 2023 | 37576402 | PubTator, text mining | PubMed |
| Inhibition of Ezh2 redistributes bivalent domains within transcriptional regulators associated with WNT and Hedgehog pathways in osteoblasts. | J Biol Chem | 2023 | 37572850 | PubTator, text mining | PubMed |
| Design, synthesis and evaluation of EZH2-based PROTACs targeting PRC2 complex in lymphoma. | Bioorg Chem | 2023 | 37572533 | PubTator, text mining | PubMed |
| YY1 Knockdown Relieves the Differentiation Block and Restores Apoptosis in AML Cells. | Cancers (Basel) | 2023 | 37568827 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8726/papers?page=11